About the Company
cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CDTX News
Cidara Therapeutics gets grant for conjugates for treating viral infections
Discover how Cidara Therapeutics' patented conjugates can revolutionize the treatment of viral infections, specifically influenza, with innovative compositions and methods.
Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve ...
Cidara Therapeutics Granted Nasdaq Listing Extension
Cidara Therapeutics (CDTX) has released an update. Cidara Therapeutics, Inc. has been granted an extension by the Nasdaq ...
Cidara Therapeutics Inc (CDTX) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Cidara Therapeutics, Inc. (CDTX)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Cidara Therapeutics Inc CDTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Cidara Therapeutics Inc.
Rates under 4% came and went during the Covid pandemic, but home prices soared. Here's what buyers and sellers face as the housing season ramps up.
Cidara Therapeutics Inc
These dividend stocks should prosper regardless of what happens with interest rates in 2024.
Cidara Therapeutics Inc CDTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...